Newspaper Editor Takes On Anti-CL Health Minister
This article was originally published in PharmAsia News
The head editor of the Bangkok Post said in a commentary Thailand's new minister of Public Health caused his own problems by opposing the government's compulsory licensing policy for drug companies. The commentary said the minister was facing "troubles of his own making" for threatening to eliminate the policy, among other issues, instead of focusing on health care. The Post editor-in-chief said Prime Minister Samak Sundaravej has defended his health minister by saying he was being "unfairly vilified for favoring pharmaceutical manufacturers." The editor said he did not believe Health Minister Chaiya Sasomsab would "easily give up his intention to have the CL policy revised." (Click here for more
You may also be interested in...
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.
During Q3 biopharmas reached $41.7bn in merger and acquisition value and drew in $44.4bn in potential deal value from alliances. Device company M&A values reached $17.9bn while in vitro diagnostic firms and research tools players completed M&A activity that totaled $8.2bn.